BCAT1 and glioblastoma: We found that silencing BCAT1 with shRNA (Figure 3A) decreased the cell proliferation, migration, and invasion of GBM cells, as assessed with CCK-8 (Figure 3B), transwell assays (Figure 3C,D), and cell scratch (Figure 3E,F), respectively.